GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MindBio Therapeutics Corp (FRA:WF6) » Definitions » Accounts Payable

MindBio Therapeutics (FRA:WF6) Accounts Payable : €0.36 Mil (As of Sep. 2024)


View and export this data going back to 2023. Start your Free Trial

What is MindBio Therapeutics Accounts Payable?

MindBio Therapeutics's Accounts Payable for the quarter that ended in Sep. 2024 was €0.36 Mil.

MindBio Therapeutics's quarterly Accounts Payable increased from Mar. 2024 (€0.31 Mil) to Jun. 2024 (€0.33 Mil) and increased from Jun. 2024 (€0.33 Mil) to Sep. 2024 (€0.36 Mil).

MindBio Therapeutics's annual Accounts Payable declined from Jun. 2022 (€0.79 Mil) to Jun. 2023 (€0.35 Mil) and declined from Jun. 2023 (€0.35 Mil) to Jun. 2024 (€0.33 Mil).


MindBio Therapeutics Accounts Payable Historical Data

The historical data trend for MindBio Therapeutics's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MindBio Therapeutics Accounts Payable Chart

MindBio Therapeutics Annual Data
Trend Jun21 Jun22 Jun23 Jun24
Accounts Payable
0.05 0.79 0.35 0.33

MindBio Therapeutics Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.31 0.28 0.31 0.33 0.36

MindBio Therapeutics Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.


MindBio Therapeutics Accounts Payable Related Terms

Thank you for viewing the detailed overview of MindBio Therapeutics's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


MindBio Therapeutics Business Description

Traded in Other Exchanges
Address
91-97 William Street, Level 4, Melbourne, VIC, AUS, 3000
MindBio Therapeutics Corp is engaged in the research, development, and testing of psychedelic substances as a potential treatment for the management of a broad range of mental health conditions. The company invests in clinical research to discover potential new treatment options and aims to create novel medicines and treatment regimes from breakthrough micro dosing studies. Geographically, the company's activities take place in Australia.

MindBio Therapeutics Headlines

No Headlines